AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

IVVD · NASDAQ · Biotechnology

Invivyd (IVVD)

Develops monoclonal antibodies for serious viral diseases, beginning with COVID-19 prevention.

$0.8596

Pre-market+0.05 (+6.58%)

At close$0.8065(−8.34%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions146 holders · as of Mar 31, 2026 · largest filers plus last quarter's tail	≈ 76.68%	226.03M shares
Insiders8 holders · as of Aug 18, 2026	5.20%	15.34M shares
Strategic holders1 holder · as of Dec 29, 2025	6.87%	20.26M shares
Otherremainder	≈ 11.25%	33.13M shares

294.76M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Janus Henderson Group PLCInstitution	11.23%	33.09M	13Fas of Mar 31, 2026
RA Capital Management, L.P.Institution	7.24%	21.34M	13Gfiled May 15, 2026 ↗
Perceptive Advisors LLCInstitution	7.08%	20.86M	13Fas of Mar 31, 2026
Adimab, LLC^1,2Strategic10 percent owner	6.87%	20.26M	13Dfiled Dec 29, 2025 ↗
BVF Inc/ILInstitution	6.62%	19.53M	13Fas of Mar 31, 2026
Maverick Capital LtdInstitution	6.44%	18.97M	13Fas of Mar 31, 2026
Ajay RoyanInsiderdirector	3.81%	11.24M	Form 4filed Mar 26, 2025 ↗
Saturn V Capital Management LLCInstitution	3.71%	10.95M	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	3.42%	10.07M	13Fas of Mar 31, 2026
M28 Capital Management LPInstitution	3.14%	9.25M	13Fas of Mar 31, 2026
Eventide Asset Management, LLCInstitution	3.08%	9.07M	13Fas of Mar 31, 2026
Driehaus Capital Management LLCInstitution	2.86%	8.44M	13Fas of Mar 31, 2026
Soleus Capital Management, L.P.Institution	2.62%	7.71M	13Fas of Mar 31, 2026
State Street CorpInstitution	2.35%	6.94M	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	1.45%	4.28M	13Fas of Mar 31, 2026
Siren, L.L.C.Institution	1.36%	4.00M	13Fas of Mar 31, 2026
Adar1 Capital Management, LLCInstitution	1.30%	3.82M	13Fas of Mar 31, 2026
Adage Capital Partners GP, L.L.C.Institution	1.24%	3.66M	13Fas of Mar 31, 2026
Balyasny Asset Management L.P.Institution	1.19%	3.52M	13Fas of Mar 31, 2026
Millennium Management LLCInstitution	1.19%	3.51M	13Fas of Mar 31, 2026
Morgan StanleyInstitution	1.15%	3.39M	13Fas of Mar 31, 2026
Terrance McguireInsiderdirector	1.04%	3.07M	Form 4filed Dec 31, 2024 ↗
Qube Research & Technologies LtdInstitution	0.91%	2.69M	13Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution	0.90%	2.66M	13Fas of Mar 31, 2026
Redmile Group, LLCInstitution	0.90%	2.65M	13Fas of Mar 31, 2026

Adimab, LLC's transaction reports restate only vehicles that traded; the 2025 ownership statement (20.26M) is used instead.
Adimab, LLC reports a block also reported by Perceptive Advisors LLC; it is counted once, under Perceptive Advisors LLC.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

146 holders · 226.03M shares · 42 new positions · 80 increased · 27 reduced · 18 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Janus Henderson Group PLC	33.09M	11.23%	+551.2K	May 18, 2026
Perceptive Advisors LLC	20.86M	7.08%	−925.9K	May 29, 2026
BVF Inc/IL	19.53M	6.62%	0	May 15, 2026
Maverick Capital Ltd	18.97M	6.44%	0	May 15, 2026
Saturn V Capital Management LLC	10.95M	3.71%	+3.21M	May 15, 2026
Vanguard Capital Management LLC	10.07M	3.42%	+10.07Mnew	May 15, 2026
M28 Capital Management LP	9.25M	3.14%	0	May 14, 2026
Eventide Asset Management, LLC	9.07M	3.08%	+3.26M	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Janus Henderson Group PLC	12.10%	25.38M	13G	Nov 14, 2025 ↗
Perceptive Advisors LLC	7.90%	21.79M	13G	Nov 25, 2025 ↗
Adimab, LLC	7.30%	20.26M	13D	Dec 29, 2025 ↗
RA Capital Management, L.P.	7.00%	21.34M	13G	May 15, 2026 ↗
Maverick Capital, Ltd.	6.70%	18.97M	13G	Feb 13, 2026 ↗
BlackRock, Inc.	5.50%	16.12M	13G	Jul 28, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Aug 18, 2026	Robert D. III Allenofficer: Chief Scientific Officer	Sale	17,043	$0.8429	178,765
Aug 17, 2026	Robert D. III Allenofficer: Chief Scientific Officer	Sale	20,679	$0.7220	195,808
Aug 18, 2026	Jill Andersenofficer: Chief Legal Officer, Secretary	Sale	30,706	$0.8429	283,774
Aug 17, 2026	Jill Andersenofficer: Chief Legal Officer, Secretary	Sale	37,256	$0.7220	314,480
Aug 18, 2026	William E. Dukeofficer: Chief Financial Officer	Sale	18,425	$0.8429	168,937
Aug 17, 2026	William E. Dukeofficer: Chief Financial Officer	Sale	22,355	$0.7220	187,362
Aug 18, 2026	Julie Greenofficer: Chief Human Resources Officer	Sale	18,425	$0.8429	168,937
Aug 17, 2026	Julie Greenofficer: Chief Human Resources Officer	Sale	22,355	$0.7220	187,362
Aug 18, 2026	Timothy Edward Leeofficer: Chief Commercial Officer	Sale	18,425	$0.8429	178,937
Aug 17, 2026	Timothy Edward Leeofficer: Chief Commercial Officer	Sale	22,355	$0.7220	197,362

CongressHouse and Senate disclosures

Not reported.